GB2076289A - Antiperspirant compositions - Google Patents
Antiperspirant compositions Download PDFInfo
- Publication number
- GB2076289A GB2076289A GB8116054A GB8116054A GB2076289A GB 2076289 A GB2076289 A GB 2076289A GB 8116054 A GB8116054 A GB 8116054A GB 8116054 A GB8116054 A GB 8116054A GB 2076289 A GB2076289 A GB 2076289A
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- composition according
- antiperspirant
- combination
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
An antiperspirant composition having any of a variety of dosage forms and containing as active antiperspirant materials a combination of an aluminum chloride and an aluminum zirconium hydroxychloride which act synergistically; the product may also contain a combination of magnesium hydroxide (or oxide) and glycine as irritation reducing agents.
Description
SPECIFICATION
Antiperspirant compositions
This invention relates to novel antiperspirant compositions. More particularly, it concerns antiperspirant compositions containing as active ingredients a combination of an aluminum chloride and an aluminum zirconium hydroxychloride.
It is known in the prior art to use aluminum chloride or aluminum zirconium hydroxychloride individually as antiperspirant materials. We have now found, however, when these materials are employed together they act synergistically giving unexpected high activity and response rate.
It is accordingly an object of the present invention to provide a high performance antiperspirant composition containing as active antiperspirant material a combination of an aluminum chloride and an aluminum zirconium hydroxychloride.
It is also an object of the present invention to provide a method for inhibiting perspiration in subjects by applying to the skin of such subjects an antiperspirant effective amount of compositions containing in combination an aluminum chloride and an aluminum zirconium hydroxychloride.
Other and more detailed objects of this invention will be apparent from the following description and claims.
Unless otherwise indicated the percentages are given in percent by weight based on the total weight of the composition.
It is known that certain types of people will respond to particular types of antiperspirant salts; it being unusual to find more than 60-70% of an antiperspirant panel responding to any one given material. However, when the combination of active ingredients of this invention was used over 93% of the panel participants responded favorably. Additionally, surprisingly high activities were recorded; 88% had superior activity. It has always been believed that the activity mechanisms for different salts differ. What has been discovered here is a combination product that allows activity responses from more than one mechanism.
Normally speaking, one would have expected this combination to be very irritating, since the pH of this solution is very acidic. We have also found that raising the pH alone is not enough to alleviate the irritation response. However, we have also discovered that the use of divalent oxides or hydroxides in combination with small amounts of glycine solve this problem. The alkali earth metal salts or glycine alone can improve the irritation potential problem somewhat; however, it can be essentially eliminated completely with the combination of the divalent metal oxides or hydroxides and glycine used in line with the instant discovery.
The quantity of the aluminum chloride that may be contained in the compositions of the present invention may vary somewhat. For the most part, they will constitute between about 5 and about 25% by weight based on the total weight of the composition and preferably 7.5% to about 15% by weight. As used herein, the term "an aluminum chloride" is intended to refer to anhydrous aluminum chloride as well as its hydrated and hydroxide forms e.g. AlCl3.6H2O or Al2(OH)5Cl.
The aluminum zirconium hydroxychlorides that are employed in the present invention are well known in the prior art and may be described by the general formula: Al4ZnO(OH)14~n CI, H20 wherein N has the value 0 to 1 4 and x has the value of from 0 to 20. By way of example, mention may be made of compounds of formulas:
Al4 ZrO (OH)" Cl3 ; and
Al ZrO (OH)o C14 and their corresponding hydrates.
The amount of the aluminum zirconium hydroxychloride that may be contained in the composition of this invention may also vary somewhat. Usually, however, it will comprise between about 2% to about 20% by weight based on the total weight of the composition and preferably between about 5% to about 10%.
An important feature of the present compositions is the ratio of the aluminum salt and the
Al/Zr salt that they contain. This ratio will be in the range of from about 0.5 to about 2; the preferred range being from about 1.25 to about 1.75.
Another important relationship in the present compositions is the metal:chloride mole ratio. It is important that this be less than .9 to retain the ionic character of the complex which is related to its antiperspirant activity. 0
As indicated previously, it is highly advantageous to use a combination of magnesium hydroxide (or oxide) and glycine to adjust the pH of our compositions. This combination.will ordinarily be used to adjust the pH in the range of from about 2.5 to about 4.5. The glycine will be employed at a level of from about 0.25% to about 5% by weight based on the total weight of the composition; whereas, the magnesium hydroxide (or oxide) will constitute about 1 % to about 9%. The ratio of glycine to magnesium hydroxide (or oxide) is also an important factor.
This ratio may be in the range of from about .025 to about 5 but we prefer to employ a ratio in the range of from about 0.1 to about 1.0.
The novel combination of antiperspirant materials and the pH adjusting agents described above may be incorporated in any of a variety of dosage forms useful for delivering the antiperspirant material. They may be incorporated in a lotion, in a cream or gel, in a foam system, in an aerosol dispensing system, in a pump spray system, as part of an antiperspirant stick or may be delivered in the form of a solution in a suitable solvent vehicle. The following are illustrations of types of formulas in which the present compositions may be employed as active antiperspirant materials:
A. Roll-On (Lotions and Creams)
Actives 25%
Emollients 2-4%
Surface active agents 2-4%
Buffering systems 2-7% Waterq.s. -100% B.Suspension-Anhydrous can be used in the formulation of Aerosols and Aerosol Foams
Actives 25%
Emollients 5-1 5% Suspending agents 2-5%
Buffering agents 2-4% Water 100% Aerosol
Above 70-85%
Propellant 15-30%
C. Sticks
Actives 25%
Gelling agent 2-4%
Waxes 5-20%
Emollients 5-20%
Buffering agents 2-4% Externalphase q.s. 100% *Anhydrous solent
The following Examples are given to further illustrate the present invention. It is understood, however, that the invention is not limited thereto.
EXAMPLE 1
Roll-On Lotion (Emulsion o/w)
% by weight AICI3. 6H20 15.00 Mg(OH)2 3.75 Al/Zr trichlorohydrate' 10.00
Brij 72 (Polyoxyethylene 2 Stearyl Ether) 3.00
Brij 78 (Polyoxyethylene 20 Stearyl Ether) 1.00
Glycine 0.50
Disodium EDTA 0.10
Polyoxypropylene 1 5 Stearyl Ether (Arlamol E) 4.00
H20 62.65
100.00
EXAMPLE 2
Clear Water Solution (Pump Spray) AlCI3. 6H2O 15.00 Mg(OH)2 3.75 Glycine 0.50
Al/Zr trichlorohydrate' 10.00 H20 65.75
Procetyl AWS (PPG-5 Cetheth 20) 5.00
100.00
EXAMPLE 3
Aerosol Antiperspirant
Al/Complex Powder2 6.00
Al/Zr trichlorohydrate1 4.00
Dibutyl phthalate 11.00
Cabosil M-5 0.30
Bentone 34 0.10
Isobutane 78.60
100.00 ' Al4ZrO(OH),1CI3 2 Product prepared by spray drying AICI3;Mg(OH)2 and glycine in the weight ratio of 4:1:.5 EXAMPLE 4
Stick Antiperspirant
Al/Complex Powder 1 5.00 Al/Zr trichlorohydrate 1 0.00 Stearyl alcohol 20.00
Dibutyl phthalate 41.00
Procetyl AWS (PPG-5 Cetheth 20) 10.00
Montan wax 4.00 100.00 To demonstrate the fact that the combination of the aluminum choride and the aluminum zirconium hydroxychloride act synergistically as antiperspirants, three compositions were prepared identified as Compositions A, B and C which were the same in all respects excepting the active antiperspirant material.Composition A contained 25% by weight of aluminum zirconium hydroxychloride; Composition B contained 10% by weight of aluminum zirconium hydroxychloride and 15% by weight of aluminum chloride; and Composition C contained 25% by weight of aluminum chloride. Each of these compositions were tested for antiperspirant activity on a group of individuals that served as an antiperspirant panel. The procedure employed was as described in Federal Register, Vol. 43, Number 196, October 10, 1978 and is called the Gravemetric
Axillary Antiperspirant Test.
The results of this test are summarized in Table I below which gives the formulas of
Compositions A, B and C as well as the antiperspirant activity measured for each composition.
TABLE I
A B C
Aluminum Zirconium hydroxide Complex 26 10 O Aluminum Chloride - 1 5 25
Emollient 2-4 2-4 2-4
Surface Active Agents 2-4 2-4 2-4
q.s. buffer to pH
3.2 + .3
q.s. water to 100% pH at time of test 3.5 3.2 3.4
Activity 50% 62% 53%
As will be seen from the above Table, a 20-25% enhancement of antiperspirant activity is obtained with a combination of aluminum chloride and aluminum zirconium hydroxychloride as compared with the use of aluminum chloride or aluminum zirconium hydroxychloride.
Although the invention has been described with reference to specific forms thereof, it will be understood that many changes and modifications may be made without departing from the scope of this invention.
Claims (11)
1. An antiperspirant composition comprising a carrier and as active antiperspirant material a combination of an aluminum chloride and aluminum zirconium hydroxychloride, said combination comprising, based on the total weight of the composition, from about 5% to about 25% by weight of an aluminum chloride and from about 2% to about 20% by weight of an aluminum zirconium hydroxychloride; the ratio of aluminum salt to Al/Zr salt in said composition being in the range of from about 0.5 to about 2 and the mole ratio of metal to chloride being less than .9.
2. A composition according to Claim 1 including as a pH adjusting agent a combination of magnesium hydroxide or oxide and glycine, said magnesium hydroxide or oxide constituting from about 1 % to about 9% by weight of said composition and said glycine constituting from about 0.25% to about 5% by weight of said composition.
3. A composition according to Claim 1 or 2 in the form of a lotion.
4. A composition according to Claim 1 or 2 in the form of a solution.
5. A composition according to Claim 1 or 2 in the form of a stick.
6. A composition according to Claim 1 or 2 in the form of an aerosol composition.
7. A composition according to Claim 1 or 2 in the form of a pump spray composition.
8. A composition according to Claim 1 or 2 in the form of a cream or a gel.
9. A composition according to Claim 1 or 2 in the form of a foam.
10. A method for inhibiting perspiration in a subject which comprises applying to the skin of said subject an antiperspirant effective amount of a composition defined in Claims 1 through 9.
11. A composition according to claim 1, substantially as described in any of the foregoing
Examples.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15311380A | 1980-05-27 | 1980-05-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2076289A true GB2076289A (en) | 1981-12-02 |
GB2076289B GB2076289B (en) | 1985-01-09 |
Family
ID=22545825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8116054A Expired GB2076289B (en) | 1980-05-27 | 1981-05-26 | Antiperspirant compositions |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS5711908A (en) |
AU (1) | AU547530B2 (en) |
BE (1) | BE888975A (en) |
CA (1) | CA1140470A (en) |
CH (1) | CH644755A5 (en) |
DE (1) | DE3120742A1 (en) |
FR (1) | FR2483230A1 (en) |
GB (1) | GB2076289B (en) |
GR (1) | GR75643B (en) |
IT (1) | IT1170993B (en) |
MX (1) | MX156358A (en) |
NL (1) | NL8102540A (en) |
NZ (1) | NZ197164A (en) |
PH (1) | PH16329A (en) |
PT (1) | PT73090B (en) |
SE (1) | SE452107B (en) |
ZA (1) | ZA813484B (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4673570A (en) * | 1985-03-20 | 1987-06-16 | Carter-Wallace, Inc. | Gelled antiperspirant compositions |
US4774079A (en) * | 1980-12-15 | 1988-09-27 | Bristol-Myers Company | Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use |
US4775528A (en) * | 1983-08-16 | 1988-10-04 | The Gillette Company | Antiperspirant composition |
US5114705A (en) * | 1983-08-16 | 1992-05-19 | The Gillette Company | Antiperspirant composition |
US5298640A (en) * | 1983-08-16 | 1994-03-29 | The Gillette Company | Antiperspirant composition |
US5486347A (en) * | 1983-08-16 | 1996-01-23 | The Gillette Company | Antiperspirant composition |
US6136302A (en) * | 1999-02-18 | 2000-10-24 | The Procter & Gamble Company | Process of making zirconium-aluminum antiperspirant active |
US6375937B1 (en) | 2000-10-20 | 2002-04-23 | Colgate-Palmolive Company | Antiperspirant salts for enhanced cosmetic products |
WO2005048966A1 (en) * | 2003-11-17 | 2005-06-02 | The Procter & Gamble Company | Antiperspirant composition and applicator therefor |
US7311898B2 (en) | 2002-12-09 | 2007-12-25 | Colgate-Palmolive Company | High efficacy, low irritation aluminum salts and related products |
US7425321B2 (en) | 2001-08-17 | 2008-09-16 | L'oreal S.A. | Anhydrous antiperspirant stick |
US20120282205A1 (en) * | 2009-12-23 | 2012-11-08 | Colgate-Palmolive Company | Anhydrous liquid antiperspirant/deodorant composition |
US10342749B2 (en) | 2014-12-15 | 2019-07-09 | Conopco, Inc. | Antiperspirant compositions comprising alums |
US20190365616A1 (en) * | 2015-11-09 | 2019-12-05 | Gulbrandsen Technologies, Inc. | Activation And Stabilization Of Basic Aluminum Chloride Solution By Zinc |
US10526210B2 (en) | 2015-06-30 | 2020-01-07 | Gulbrandsen Technologies, Inc. | Method of making high performance activated aluminum sesquichlorohydrate powders |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1153313A (en) * | 1980-12-15 | 1983-09-06 | Chung T. Shin | Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use |
US4606915A (en) * | 1981-04-23 | 1986-08-19 | Bristol-Myers Company | Antiperspirant combination containing an aluminum halohydrate and a stannic halide |
JPH05112440A (en) * | 1991-08-09 | 1993-05-07 | Sayuri Takemoto | Coating agent for deodorization |
WO2015073045A1 (en) * | 2013-11-18 | 2015-05-21 | Colgate-Palmolive Company | Antiperspirant composition |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2906668A (en) * | 1955-06-13 | 1959-09-29 | Reheis Company Inc | Zirconyl and aluminum halohydroxy complex |
US3903258A (en) * | 1973-08-06 | 1975-09-02 | Gillette Co | Zirconium aluminum complexes and method of making the same |
US4017599A (en) * | 1973-11-23 | 1977-04-12 | Armour Pharmaceutical Company | Aluminum-zirconium anti-perspirant systems with salts of amino acids |
US3981986A (en) * | 1973-11-23 | 1976-09-21 | Armour Pharmaceutical Company | Zirconium-aluminum-polyol buffered anti-perspirant complexes |
AU8303275A (en) * | 1974-07-17 | 1977-01-20 | Armour Pharma | Aluminum-zirconium antiperspirant systems with trace amounts of alkaline earth metals |
JPS5454863A (en) * | 1977-10-03 | 1979-05-01 | Kubota Ltd | Stalk and straw conveying apparatus with safety cover |
-
1980
- 1980-07-09 CA CA000355786A patent/CA1140470A/en not_active Expired
-
1981
- 1981-05-21 NZ NZ197164A patent/NZ197164A/en unknown
- 1981-05-21 AU AU70928/81A patent/AU547530B2/en not_active Ceased
- 1981-05-22 GR GR65041A patent/GR75643B/el unknown
- 1981-05-22 FR FR8110236A patent/FR2483230A1/en active Granted
- 1981-05-22 NL NL8102540A patent/NL8102540A/en not_active Application Discontinuation
- 1981-05-25 DE DE19813120742 patent/DE3120742A1/en active Granted
- 1981-05-25 IT IT48527/81A patent/IT1170993B/en active
- 1981-05-25 ZA ZA00813484A patent/ZA813484B/en unknown
- 1981-05-26 CH CH345681A patent/CH644755A5/en not_active IP Right Cessation
- 1981-05-26 GB GB8116054A patent/GB2076289B/en not_active Expired
- 1981-05-26 MX MX187478A patent/MX156358A/en unknown
- 1981-05-26 BE BE0/204911A patent/BE888975A/en not_active IP Right Cessation
- 1981-05-26 PT PT73090A patent/PT73090B/en unknown
- 1981-05-27 SE SE8103369A patent/SE452107B/en not_active IP Right Cessation
- 1981-05-27 JP JP7944281A patent/JPS5711908A/en active Granted
- 1981-05-27 PH PH25676A patent/PH16329A/en unknown
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4774079A (en) * | 1980-12-15 | 1988-09-27 | Bristol-Myers Company | Antiperspirant composition containing aluminum chlorohydrate, aluminum chloride and an aluminum zirconium polychlorohydrate complex and method of use |
US5589196A (en) * | 1983-08-16 | 1996-12-31 | The Gillette Company | Antiperspirant composition |
US4775528A (en) * | 1983-08-16 | 1988-10-04 | The Gillette Company | Antiperspirant composition |
US5114705A (en) * | 1983-08-16 | 1992-05-19 | The Gillette Company | Antiperspirant composition |
US5298640A (en) * | 1983-08-16 | 1994-03-29 | The Gillette Company | Antiperspirant composition |
US5486347A (en) * | 1983-08-16 | 1996-01-23 | The Gillette Company | Antiperspirant composition |
US5770186A (en) * | 1983-08-16 | 1998-06-23 | The Gillette Company | Antiperspirant composition |
US4673570A (en) * | 1985-03-20 | 1987-06-16 | Carter-Wallace, Inc. | Gelled antiperspirant compositions |
US6136302A (en) * | 1999-02-18 | 2000-10-24 | The Procter & Gamble Company | Process of making zirconium-aluminum antiperspirant active |
US6375937B1 (en) | 2000-10-20 | 2002-04-23 | Colgate-Palmolive Company | Antiperspirant salts for enhanced cosmetic products |
EP1284128B2 (en) † | 2001-08-17 | 2010-07-21 | L'oreal | Anhydrous antiperspirant stick |
US7425321B2 (en) | 2001-08-17 | 2008-09-16 | L'oreal S.A. | Anhydrous antiperspirant stick |
US7311898B2 (en) | 2002-12-09 | 2007-12-25 | Colgate-Palmolive Company | High efficacy, low irritation aluminum salts and related products |
WO2005048966A1 (en) * | 2003-11-17 | 2005-06-02 | The Procter & Gamble Company | Antiperspirant composition and applicator therefor |
US7905673B2 (en) | 2003-11-17 | 2011-03-15 | The Procter & Gamble Company | Antiperspirant composition and applicator therefor |
US20120282205A1 (en) * | 2009-12-23 | 2012-11-08 | Colgate-Palmolive Company | Anhydrous liquid antiperspirant/deodorant composition |
US8815222B2 (en) * | 2009-12-23 | 2014-08-26 | Colgate—Palmolive Company | Anhydrous liquid antiperspirant composition |
US10342749B2 (en) | 2014-12-15 | 2019-07-09 | Conopco, Inc. | Antiperspirant compositions comprising alums |
US10526210B2 (en) | 2015-06-30 | 2020-01-07 | Gulbrandsen Technologies, Inc. | Method of making high performance activated aluminum sesquichlorohydrate powders |
US20190365616A1 (en) * | 2015-11-09 | 2019-12-05 | Gulbrandsen Technologies, Inc. | Activation And Stabilization Of Basic Aluminum Chloride Solution By Zinc |
Also Published As
Publication number | Publication date |
---|---|
PT73090B (en) | 1983-02-08 |
SE8103369L (en) | 1981-11-28 |
CH644755A5 (en) | 1984-08-31 |
AU7092881A (en) | 1981-12-03 |
DE3120742A1 (en) | 1982-03-18 |
GR75643B (en) | 1984-08-02 |
FR2483230A1 (en) | 1981-12-04 |
PT73090A (en) | 1981-06-01 |
BE888975A (en) | 1981-11-26 |
FR2483230B1 (en) | 1985-01-04 |
NZ197164A (en) | 1984-08-24 |
CA1140470A (en) | 1983-02-01 |
PH16329A (en) | 1983-09-05 |
MX156358A (en) | 1988-08-12 |
IT8148527A0 (en) | 1981-05-25 |
SE452107B (en) | 1987-11-16 |
JPS5711908A (en) | 1982-01-21 |
DE3120742C2 (en) | 1988-10-27 |
IT1170993B (en) | 1987-06-03 |
NL8102540A (en) | 1981-12-16 |
ZA813484B (en) | 1982-05-26 |
JPS6412245B2 (en) | 1989-02-28 |
AU547530B2 (en) | 1985-10-24 |
GB2076289B (en) | 1985-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2076289A (en) | Antiperspirant compositions | |
US4937069A (en) | Anhydrous semi-solid antiperspirant suspension | |
US4053581A (en) | Antiperspirant solution containing a mixture of substantially volatile and substantially non-volatile siloxane liquids | |
US4137306A (en) | Anhydrous antiperspirant stick compositions | |
US4065564A (en) | Antiperspirant solution containing a substantially non-volatile siloxane liquid | |
US4073880A (en) | Antiperspirant solution containing a substantially volatile polydimethyl siloxane liquid | |
WO2019206764A1 (en) | An antiperspirant composition | |
US20220257480A1 (en) | An antiperspirant composition | |
JPH0239486B2 (en) | ||
AU2022287610B2 (en) | An antiperspirant composition | |
US4548808A (en) | Long-acting anhydrous antiperspirant compositions containing triacetin | |
EP0319168B1 (en) | Antiperspirant compositions | |
US5135741A (en) | Antiperspirant product | |
EP3941593B1 (en) | An antiperspirant composition comprising reactive salts | |
EP0272354A1 (en) | Antiperspirant product | |
EP3941594B1 (en) | An antiperspirant composition comprising reactive salts | |
US20230293400A1 (en) | An Antiperspirant Composition | |
US5194249A (en) | Non-whitening antiperspirant compositions | |
JP2018203683A (en) | Antiperspirant composition | |
NZ199507A (en) | Antiperspirant compositions containing an aluminium halohydrate and a stannic halide | |
EP4259066B1 (en) | An antiperspirant composition | |
EP3482741B1 (en) | Antimicrobial antiperspirant compositions | |
US20220054374A1 (en) | An antiperspirant composition comprising inorganic polyionic cluster | |
WO2019058904A1 (en) | Antiperspirant composition | |
JP2019055937A (en) | Antiperspirant composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |